Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Trikha

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|April 15, 2014
Signaling pathways involved in MDSC regulationPrashant Trikha, William E Carson
Biochimica Et Biophysica Acta. Reviews on Cancer|December 10, 2019
The role of AhR in transcriptional regulation of immune cell development and functionPrashant Trikha, Dean A Lee
Frontiers in Oncology|March 3, 2020
Editorial: Current Perspectives, Challenges and Advances in Cell Based TherapiesMonica S Thakar, Conrad Russell Cruz, Prashant Trikha
The Journal of Biological Chemistry|September 30, 2006
Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformationNidhi Sharma, Cynthia Timmers, Prashant Trikha, et al.
Free Radical Biology & Medicine|October 11, 2002
Dermal wound healing properties of redox-active grape seed proanthocyanidinsSavita Khanna, Mika Venojarvi, Sashwati Roy, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 18, 2002
Copper-induced vascular endothelial growth factor expression and wound healingChandan K Sen, Savita Khanna, Mika Venojarvi, et al.
The Journal of Biological Chemistry|December 1, 2010
E2f1-3 are critical for myeloid developmentPrashant Trikha, Nidhi Sharma, Rene Opavsky, et al.
Molecular and Cellular Biology|December 15, 2006
E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loopCynthia Timmers, Nidhi Sharma, Rene Opavsky, et al.
Molecular Cancer Therapeutics|July 27, 2016
A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck CancerErin M Bertino, Elizabeth L McMichael, Xiaokui Mo, et al.
The Journal of Allergy and Clinical Immunology|August 11, 2018
Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cellsJolie R Schafer, Travis C Salzillo, Nitin Chakravarti, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|April 15, 2014
Signaling pathways involved in MDSC regulationPrashant Trikha, William E Carson
Biochimica Et Biophysica Acta. Reviews on Cancer|December 10, 2019
The role of AhR in transcriptional regulation of immune cell development and functionPrashant Trikha, Dean A Lee
Frontiers in Oncology|March 3, 2020
Editorial: Current Perspectives, Challenges and Advances in Cell Based TherapiesMonica S Thakar, Conrad Russell Cruz, Prashant Trikha
The Journal of Biological Chemistry|September 30, 2006
Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformationNidhi Sharma, Cynthia Timmers, Prashant Trikha, et al.
Free Radical Biology & Medicine|October 11, 2002
Dermal wound healing properties of redox-active grape seed proanthocyanidinsSavita Khanna, Mika Venojarvi, Sashwati Roy, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 18, 2002
Copper-induced vascular endothelial growth factor expression and wound healingChandan K Sen, Savita Khanna, Mika Venojarvi, et al.
The Journal of Biological Chemistry|December 1, 2010
E2f1-3 are critical for myeloid developmentPrashant Trikha, Nidhi Sharma, Rene Opavsky, et al.
Molecular and Cellular Biology|December 15, 2006
E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loopCynthia Timmers, Nidhi Sharma, Rene Opavsky, et al.
Molecular Cancer Therapeutics|July 27, 2016
A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck CancerErin M Bertino, Elizabeth L McMichael, Xiaokui Mo, et al.
The Journal of Allergy and Clinical Immunology|August 11, 2018
Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cellsJolie R Schafer, Travis C Salzillo, Nitin Chakravarti, et al.
Pageof 3